Spots Global Cancer Trial Database for Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Official Title: Phase 0 Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Study ID: NCT05462951
Conditions
Interventions
Study Description
Brief Summary: This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer. Women receive standard-of-care radiochemotherapy followed by brachytherapy. Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor cells.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Markey Cancer Center, Lexington, Kentucky, United States
Contact Details
Name: Denise Fabian, MD
Affiliation: University of Kentucky
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
